Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA‐NCI roundtable symposium
Year: 2014
Type: article
Source: American Journal of Hematology
DOI: 10.1002/ajh.23831
Institutions: National Cancer Institute, United States Food and Drug Administration, St James's University Hospital, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Royal Hallamshire Hospital, Hospital de Egas Moniz, Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Hospital of St. Francis Xavier, Roswell Park Comprehensive Cancer Center, Cedars-Sinai Medical Center, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W2129104200
